跳至主要内容
临床试验/EUCTR2014-000980-42-AT
EUCTR2014-000980-42-AT进行中(未招募)不适用

Feasibility and safety of intensified preoperative glucose control in patients with type 2 diabetes undergoing cardiovascular surgery – a pilotstudy - Diabetes and cardiothoracic surgery

Medical University Vienna0 个研究点目标入组 40 人开始时间: 2014年9月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • oAge 18 – 75 years
  • oType 2 diabetes mellitus with diet alone or oral antidiabetic agents and/or insulin therapy
  • oplanned severe cardiovascular surgery
  • osigned informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • omental condition rendering the patient unable to give informed consent
  • odiagnosis and/or treatment of cancer during the last five years
  • oimpaired renal function (creatinine ?3.0mg/dl)
  • odiabetic ketoacidosis
  • oHbA1c >13%
  • ocardiothoracic surgery in the previous 12 months
  • oPregnant or breast-feeding patients

研究者

发起方
Medical University Vienna

相似试验